Stock Scorecard



Stock Summary for BioNTech SE (BNTX) - $105.27 as of 5/27/2023 12:07:21 AM

Total Score

18 out of 29

Currently on the following lists
Dividend Stock List
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for BNTX

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for BNTX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for BNTX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for BNTX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for BNTX

Top Stories Friday, May 26: Amazon's Prime Video Trolls Netflix's Password Crackdown, Tesla Data Leak Exposes Safety Nightmare, Elon Musk's Brain Chip Company Gets FDA Nod For Human Trial - AstraZeneca ( NASDAQ:AZN ) , Amazon.com ( NASDAQ:AMZN ) 5/26/2023 12:42:00 PM
Amended European Deal For BioNTech-Pfizer's Covid-19 Vaccines Allows Reduced Purchases - Pfizer ( NYSE:PFE ) , BioNTech ( NASDAQ:BNTX ) 5/26/2023 11:53:00 AM
EU, Pfizer/BioNTech announce amendment to COVID vaccine contract 5/26/2023 8:34:00 AM
Why Pfizer Stock Slipped by 2% Today 5/25/2023 10:03:00 PM
BioNTech's Ready-to-Use Single Dose Vaccine, the Perfect Counterattack to China's Rising XBB1.5 Cases - BioNTech ( NASDAQ:BNTX ) 5/25/2023 6:10:00 PM
BioNTech is proceeding with COVID-shot in line with WHO guidance 5/25/2023 12:47:00 PM
As Debt Ceiling Talks Wobble, Investors Look To May Fed Minutes, Nvidia Earnings For Direction - AstraZeneca ( NASDAQ:AZN ) , BioNTech ( NASDAQ:BNTX ) 5/24/2023 5:33:00 PM
Why Novavax, Pfizer And BioNTech Shares Are Rising Today - Novavax ( NASDAQ:NVAX ) 5/24/2023 12:47:00 PM
2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years 5/23/2023 12:20:00 PM
Here's what Pfizer and Moderna say is next for their Covid vaccines 5/22/2023 4:22:00 PM

Financial Details for BNTX

Company Overview

Company Name BioNTech SE
Country USA
Description BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany.
Sector Name LIFE SCIENCES
Industry Name BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Most Recent Quarter 3/31/2023
Next Earnings Date 8/7/2023

Stock Price History

Last Day Price 105.27
Last Day Volume 871,090
Average Daily Volume 815,027
52-Week High 188.99
52-Week Low 100.08
Last Price to 52 Week Low 5.19 %

Valuation Measures

Trailing PE 4.11
Industry PE 213.94
Sector PE 75.80
5-Year Average PE 27.25
Free Cash Flow Ratio 2.09
Industry Free Cash Flow Ratio 35.79
Sector Free Cash Flow Ratio 37.36
Current Ratio Most Recent Quarter 12.95
Total Cash Per Share 50.39
Book Value Per Share Most Recent Quarter 84.09
Price to Book Ratio 2.33
Industry Price to Book Ratio 11.07
Sector Price to Book Ratio 15.29
Price to Sales Ratio Twelve Trailing Months 2.38
Industry Price to Sales Ratio Twelve Trailing Months 42.22
Sector Price to Sales Ratio Twelve Trailing Months 24.84

Share Statistics

Total Shares Outstanding 240,990,000
Market Capitalization 25,369,017,300
Institutional Ownership 0.00 %

Dividends

Ex-Dividend Date 6/2/2022
Last Dividend Amount 3.65
Current Dividend Amount 2.11
Dividend Aristocrat? False
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00 %
Trailing Annual Dividend Rate 3.65
Trailing Annual Dividend Yield 1.33 %
5-Year Average Dividend Yield 0.00 %
5-Year Dividend Payments Count 1
Dividend Payout Ratio 0.00 %

Income Statement

Quarterly Earnings Growth YOY -85.60 %
Annual Earnings Growth -8.34 %
Reported EPS Past Year 2.05
Reported EPS Prior Year 36.93
Net Income Twelve Trailing Months 6,237,800,000
Net Income Past Year 9,434,400,000
Net Income Prior Year 10,292,500,000
Quarterly Revenue Growth YOY -80.00 %
5-Year Revenue Growth 241.30 %

Balance Sheet

Total Cash Most Recent Quarter 12,143,900,000
Total Cash Past Year 13,875,100,000
Total Cash Prior Year 1,692,700,000
Net Cash Position Most Recent Quarter 11,971,500,000
Net Cash Position Past Year 13,698,900,000
Long Term Debt Past Year 176,200,000
Long Term Debt Prior Year 171,600,000
Total Debt Most Recent Quarter 172,400,000
Equity to Debt Ratio Past Year 0.99
Equity to Debt Ratio Most Recent Quarter 0.99
Total Stockholder Equity Past Year 20,055,600,000
Total Stockholder Equity Prior Year 11,893,700,000
Total Stockholder Equity Most Recent Quarter 20,265,300,000

Options

Put/Call Ratio 1.07
Has Options Options Chain
Liquidity Rating

Technical Analysis

MACD -2.26
MACD Signal -3.82
20-Day Bollinger Lower Band 139.84
20-Day Bollinger Middle Band 161.18
20-Day Bollinger Upper Band 182.52
Beta 0.21
RSI 50.68
50-Day SMA 142.40
200-Day SMA 0.00

System

Modified 5/27/2023 12:07:21 AM